{"product_id":"onco-nephrology","title":"Onco-Nephrology","description":"\u003cp data-mce-fragment=\"1\"\u003e\u003cspan data-mce-fragment=\"1\"\u003eKidney disease and cancer are frequent comorbidities that require specialized knowledge and expertise from both the nephrologist and the oncologist. Written by three pioneers in this growing subspecialty, \u003c\/span\u003e\u003cspan class=\"a-text-italic\" data-mce-fragment=\"1\"\u003eOnco-Nephrology\u003c\/span\u003e\u003cspan data-mce-fragment=\"1\"\u003e provides \u003c\/span\u003e\u003cspan class=\"a-text-bold\" data-mce-fragment=\"1\"\u003eauthoritative, definitive coverage of the mechanism and management of these two life-threatening diseases\u003c\/span\u003e\u003cspan data-mce-fragment=\"1\"\u003e. This unique, single-volume resource covers current protocols and recommends management therapies to arrest kidney failure and allow oncologic treatments to continue and succeed\u003c\/span\u003e\u003cspan class=\"a-text-italic\" data-mce-fragment=\"1\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cul class=\"a-unordered-list a-vertical\" data-mce-fragment=\"1\"\u003e\n\u003cli data-mce-fragment=\"1\"\u003e\u003cspan class=\"a-list-item\" data-mce-fragment=\"1\"\u003e\u003cspan data-mce-fragment=\"1\"\u003eAddresses \u003c\/span\u003e\u003cspan class=\"a-text-bold\" data-mce-fragment=\"1\"\u003eacute and chronic kidney diseases that develop from a variety of cancers\u003c\/span\u003e\u003cspan data-mce-fragment=\"1\"\u003e. This includes direct kidney injury from the malignancy, paraneoplastic effects of the cancer, and various cancer agents used to treat the malignancy.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-mce-fragment=\"1\"\u003e \u003cbr data-mce-fragment=\"1\"\u003e\u003c\/p\u003e\n\u003cul class=\"a-unordered-list a-vertical\" data-mce-fragment=\"1\"\u003e\n\u003cli data-mce-fragment=\"1\"\u003e\u003cspan class=\"a-list-item\" data-mce-fragment=\"1\"\u003e\u003cspan data-mce-fragment=\"1\"\u003eDiscusses \u003c\/span\u003e\u003cspan class=\"a-text-bold\" data-mce-fragment=\"1\"\u003ekey issues regarding kidney disease in patients with cancer\u003c\/span\u003e\u003cspan data-mce-fragment=\"1\"\u003e, including conventional chemotherapeutic regimens and new novel therapies (targeted agents and immunotherapies) or the malignancies themselves that may promote kidney injury; patients with chronic kidney disease who acquire cancer unrelated to renal failure; and kidney transplantation, which has been shown to carry an increased risk of cancer.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-mce-fragment=\"1\"\u003e \u003cbr data-mce-fragment=\"1\"\u003e\u003c\/p\u003e\n\u003cul class=\"a-unordered-list a-vertical\" data-mce-fragment=\"1\"\u003e\n\u003cli data-mce-fragment=\"1\"\u003e\u003cspan class=\"a-list-item\" data-mce-fragment=\"1\"\u003e\u003cspan data-mce-fragment=\"1\"\u003eContains \u003c\/span\u003e\u003cspan class=\"a-text-bold\" data-mce-fragment=\"1\"\u003ededicated chapters for each class of the conventional chemotherapeutic agents\u003c\/span\u003e\u003cspan data-mce-fragment=\"1\"\u003e, targeted cancer agents, and cancer immunotherapies including the basic science, pathogenic mechanisms of injury, clinical manifestations, and treatment.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-mce-fragment=\"1\"\u003e \u003cbr data-mce-fragment=\"1\"\u003e\u003c\/p\u003e\n\u003cul class=\"a-unordered-list a-vertical\" data-mce-fragment=\"1\"\u003e\n\u003cli data-mce-fragment=\"1\"\u003e\u003cspan class=\"a-list-item\" data-mce-fragment=\"1\"\u003e\u003cspan data-mce-fragment=\"1\"\u003eIncludes \u003c\/span\u003e\u003cspan class=\"a-text-bold\" data-mce-fragment=\"1\"\u003especial chapters\u003c\/span\u003e\u003cspan data-mce-fragment=\"1\"\u003e devoted to the individual classes of chemotherapies that relate to kidney disease for quick reference. Discusses \u003c\/span\u003e\u003cspan class=\"a-text-bold\" data-mce-fragment=\"1\"\u003eincreasingly complex problems\u003c\/span\u003e\u003cspan data-mce-fragment=\"1\"\u003e due to more numerous and specialized anti-cancer drugs, as well as increased survival rates for both cancer and renal failure requiring long-term patient care.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-mce-fragment=\"1\"\u003e \u003cbr data-mce-fragment=\"1\"\u003e\u003c\/p\u003e\n\u003cul class=\"a-unordered-list a-vertical\" data-mce-fragment=\"1\"\u003e\n\u003cli data-mce-fragment=\"1\"\u003e\u003cspan class=\"a-list-item\" data-mce-fragment=\"1\"\u003e\u003cspan data-mce-fragment=\"1\"\u003eCovers \u003c\/span\u003e\u003cspan class=\"a-text-bold\" data-mce-fragment=\"1\"\u003eanti-VEGF (antivascular endothelial growth factor) agents and cancer immunotherapies\u003c\/span\u003e\u003cspan data-mce-fragment=\"1\"\u003e – treatments that are being recognized for adverse kidney effects.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-mce-fragment=\"1\"\u003e \u003cbr data-mce-fragment=\"1\"\u003e\u003c\/p\u003e\n\u003cul class=\"a-unordered-list a-vertical\" data-mce-fragment=\"1\"\u003e\n\u003cli data-mce-fragment=\"1\"\u003e\u003cspan class=\"a-list-item\" data-mce-fragment=\"1\"\u003e\u003cspan data-mce-fragment=\"1\"\u003eUtilizes a clear, logical format \u003c\/span\u003e\u003cspan class=\"a-text-bold\" data-mce-fragment=\"1\"\u003ebased on the ASN Core Curriculum for Onco-Nephrology\u003c\/span\u003e\u003cspan data-mce-fragment=\"1\"\u003e, making this reference an excellent tool for board review, as well as a practical resource in daily practice.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul class=\"a-unordered-list a-vertical\" data-mce-fragment=\"1\"\u003e\n\u003cli data-mce-fragment=\"1\"\u003e\u003cspan class=\"a-list-item\" data-mce-fragment=\"1\"\u003e\u003cspan class=\"a-text-bold\" data-mce-fragment=\"1\"\u003eEnhanced\u003cspan data-mce-fragment=\"1\"\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan class=\"a-text-bold\" data-mce-fragment=\"1\"\u003eeBook version included with purchase.\u003cspan data-mce-fragment=\"1\"\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan class=\"a-text-bold\" data-mce-fragment=\"1\"\u003eYour enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":44124773941486,"sku":"9780323549455","price":281.94,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0630\/9612\/7726\/products\/9780323549455.jpg?v=1681374147","url":"https:\/\/bookland.com.au\/products\/onco-nephrology","provider":"Book Land AU","version":"1.0","type":"link"}